Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Enovis Corporation

Market Cap 1.23B 1.07B 991M 925M 1.74B 116B 1.75B 11.78B 4.58B 56.97B 4.6B 4.5B 198B P/E 2026 *
175x
P/E 2027 * 22.1x
Enterprise Value 2.42B 2.12B 1.96B 1.83B 3.43B 229B 3.46B 23.28B 9.06B 113B 9.1B 8.9B 391B EV / Sales 2026 *
1.03x
EV / Sales 2027 * 0.93x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-3.05%
1 week+1.53%
Current month-6.08%
1 month-11.95%
3 months-2.52%
6 months-21.69%
Current year-20.05%
1 week 20.61
Extreme 20.61
22.24
1 month 20.55
Extreme 20.55
25.03
Current year 20.55
Extreme 20.55
29.89
1 year 20.55
Extreme 20.55
36.82
3 years 20.55
Extreme 20.55
66.14
5 years 20.55
Extreme 20.55
164.01
10 years 20.55
Extreme 20.55
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Chief Administrative Officer

1,000 0.0017%
06-10Free

Chief Administrative Officer

1,000 0.0017%
06-10Buy

Chief Administrative Officer

1,200 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
-3.05%+1.53%-29.26%-64.69% 1.23B
-1.01%-1.06%-18.87%+2.28% 117B
+0.13%-1.55%+3.15%-9.91% 12.52B
+0.39%+0.81%+30.99%+95.43% 7.7B
+0.89%-1.54%-46.25%-70.77% 4.1B
-1.23%-1.72%+18.00%+36.84% 2.52B
-2.67%-3.28%-16.52%-15.40% 1.72B
-0.78%-3.00%+3.45%-21.06% 1.58B
+4.14%+15.49%+201.37%+165.46% 1.54B
Average -0.35%+0.58%+16.23%+13.13% 16.64B
Weighted average by Cap. -0.77%-0.89%-12.15%+5.32%

Financials

2026 *2027 *
Net sales 2.34B 2.05B 1.9B 1.77B 3.32B 222B 3.35B 22.52B 8.76B 109B 8.8B 8.61B 378B 2.47B 2.16B 1.99B 1.86B 3.49B 233B 3.52B 23.69B 9.22B 115B 9.26B 9.06B 398B
Net income 2.96M 2.59M 2.39M 2.23M 4.19M 280M 4.22M 28.43M 11.06M 138M 11.11M 10.87M 478M 54.22M 47.38M 43.82M 40.9M 76.79M 5.12B 77.35M 521M 203M 2.52B 204M 199M 8.75B
Net Debt 1.2B 1.05B 968M 903M 1.7B 113B 1.71B 11.5B 4.47B 55.63B 4.5B 4.4B 193B 1.07B 931M 862M 804M 1.51B 101B 1.52B 10.24B 3.98B 49.52B 4B 3.92B 172B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
22/06/26 US$21.30 -3.05% 1,097,599
18/06/26 US$21.97 +5.37% 1,799,377
17/06/26 US$20.85 -3.38% 1,101,769
16/06/26 US$21.58 +2.86% 1,076,261
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
21.30USD
Average target price
42.30USD
Spread / Average Target
+98.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!